More News Malaysia

SHERIDAN, Wyo., May 18, 2026 /PRNewswire/ -- The Clinical Chemistry Market has never been more critical to modern medicine. With millions of diagnostic decisions made daily on the basis of blood panels, metabolic profiles, and biochemical assays, the industry sits at the heart of global healthcare delivery. A new report by Wissen Research forecasts the market to expand from USD 13.8 billion in 2025 to USD 17.8 billion by 2030, at a steady CAGR of 5.2%.

The clinical chemistry market is no longer just about routine diagnostics. We are witnessing a fundamental convergence of automation, AI, and preventive care that is redefining how laboratories operate globally. Our research indicates that organizations investing in integrated diagnostic solutions today will hold a significant competitive edge by 2030. — Mayur Jain, Senior Research Expert, Wissen Research

At the core of this growth lies an accelerating disease burden. The rising incidence of chronic conditions — diabetes, cardiovascular disease, renal ailments, and liver disorders — is driving sustained demand for clinical chemistry analyzers and reagents across hospitals, clinics, and diagnostic centers. Alongside this, continuous innovations in analyzer technology and assay development are enabling faster, more precise biochemical testing at every level of healthcare delivery.

Need Specific Data? Get a Version Built Around Your Requirements - Ask for Customization

Technology Driving the Next Wave of Clinical Chemistry Innovation

Automated technologies, improvements in sensitivity, and laboratory integrations are altering the landscape of the clinical chemistry industry. Advanced clinical chemistry instruments now come with higher throughput capacity, real-time data handling, and artificial intelligence-supported workflow optimization, making biochemical tests faster and more accurate. Reagent innovations, immunology, and multiple tests have helped enhance the efficiency of diagnostic tests for glucose, lipid panel, liver, kidney, and electrolyte analysis.

The prevalence of chronic diseases like diabetes, heart conditions, and kidney diseases is contributing to an increased need for better clinical chemistry solutions in hospitals and laboratories. Besides, advancements in laboratory automation, LIS compatibility, and demand for decentralized testing have motivated manufacturers to introduce smaller, highly automated, and convenient diagnostic solutions.

What is Driving Growth in the Clinical Chemistry Industry?

Clinical Chemistry Analyzer Market — Challenges and Limiting Factors

One of the biggest challenges that face the clinical chemistry market is the high cost of automated analyzers, chemicals used, and the laboratory itself, especially for smaller and mid-size laboratories. It is necessary to make an expensive investment to acquire these integrated systems, conduct maintenance regularly and employ laboratory experts.

The issue of test accuracy and standardization is another big challenge facing the clinical chemistry market. This involves differences in sample preparation, the chemicals used, calibration process and laboratory techniques which might lead to inconsistency of results and inaccurate diagnosis. Besides, there are tough regulatory standards for diagnostic products such as analyzers and chemicals which make it difficult to develop products.

In addition, there are issues of short turnaround time and high testing volume within the laboratories as well. These two things place strain on laboratories due to the shortage of laboratory experts to handle high-throughput analysis. Besides, there is increased pricing pressure and lack of reimbursement in some markets.

To explore the full findings, Download Sample

Recent Strategic Developments in the Clinical Chemistry Market

The deals being struck across the industry tell a clear story — companies are doubling down on next-generation clinical chemistry analyzers featuring higher throughput, enhanced automation, multi-parameter capabilities, and improved integration with Laboratory Information Systems (LIS), increasingly through partnerships rather than solo efforts.

In May 2025, Siemens Healthineers AG (Germany) announced that its Atellica analyzers, used for both clinical chemistry and immunoassay testing, have become the first in the clinical lab diagnostics field to achieve My Green Lab ACT Ecolabel Certification. This certification signifies reduced environmental impact across manufacturing, energy, water use, and waste, areas where clinical chemistry labs have significant footprints.

In March 2025, JEOL Ltd. (Japan) signed a partnership agreement with WEGO Shingene Medical Technology Co., Ltd. (China), a subsidiary of WEGO Holding, to expand the market for clinical chemistry analyzers in China.

Key Insights from Clinical Chemistry Market Analysis

Key Players in the Clinical Chemistry Market

Leading companies in the clinical chemistry market are focusing on product innovation, strategic collaborations, and expanding health-focused capabilities to strengthen their competitive position.

Global Clinical Chemistry Market — Regional Landscape and Emerging Opportunities

North America represents a prominent market for clinical chemistry owing to its well-developed healthcare system, high diagnostic testing volumes, and increased use of automated laboratory systems in hospitals and diagnostic centers. In addition, North America has been experiencing an increase in the number of patients suffering from chronic diseases including diabetes, cardiovascular diseases, and kidney diseases.

The Asia-Pacific region is expected to exhibit the highest growth rate driven by increasing healthcare penetration, growing investments in diagnostic infrastructure, and high awareness about preventive healthcare in countries like China, India, and Japan. Growing demand for cost-efficient automated analyzers and the presence of a large number of private diagnostic laboratories are driving regional market growth.

On the other hand, Europe is likely to exhibit steady growth on account of its well-established clinical laboratory networks, growing geriatric population, and increasing demand for early disease diagnosis. Latin America and Middle East & Africa represent emerging markets in the global clinical chemistry market.

Product & End Users Insights

In 2025, the BMP segment accounted for the largest share of the clinical chemistry market by test type as a result of its extensive use in routine health screenings, electrolyte balance assessment, renal function testing, and metabolic disorder diagnosis. BMP tests are frequently used in hospitals, diagnostic laboratories, and urgent care centers due to the fast and economic analysis of important biomarkers like glucose, calcium, sodium, potassium, and creatinine. Increasing prevalence of diabetes, kidney ailments, and cardiovascular diseases drives the demand for BMP testing.

Hospitals represented the leading segment in the clinical chemistry market by end user type in 2025 as a result of the high number of both inpatient and outpatient testing procedures performed in hospital laboratories. Hospitals have been increasingly using automated clinical chemistry analyzers to conduct quick, high-volume analysis of patient samples and provide a correct disease diagnosis. Higher admission rates among patients suffering from chronic conditions, increasing health screening procedures, and investments in laboratory automation drive the growth of clinical chemistry in hospitals.

Get Full Access to Forecasts, Competitive Intelligence, and Growth Opportunities — Buy the Clinical Chemistry Market Report

Market Segmentation Snapshot

The global clinical chemistry market is segmented across product, test type, technology, end users and regions:

• By Product:

• By Test Type:

• By Technology:

By End User Industries:

• By Region:

Efficiency and precision in clinical chemistry testing have been greatly enhanced due to developments in automation, high throughput analyzers, laboratory information systems, and artificial intelligence enabled diagnostics. Innovations in biomarker, reagents technology, and point of care clinical chemistry solutions are making clinical chemistry testing increasingly possible within hospitals, diagnostic laboratories, and outpatients.

The clinical chemistry market stands at an inflection point. Growing demand for early diagnosis, chronic disease monitoring, and preventive healthcare is creating sustained momentum — and companies that invest in product innovation, strategic collaborations, and expansion into emerging healthcare markets will be best positioned to capture what lies ahead.

Expert Profile | Mayur Jain, Wissen ResearchMayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.

Email: [email protected]LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,Gould St, Ste R,Sheridan, WY 82801,Phone: (+1) 510 240 9853Email: [email protected] Website: https://www.wissenresearch.com/ Blog: https://www.wissenresearch.com/insights/ LinkedIn: https://www.linkedin.com/company/wissen-research

Logo: https://mma.prnewswire.com/media/2971885/5971203/Wissen_Research_Logo.jpg

SOURCE Wissen Research LLC

...